Aditxt, Inc. (ADTX )
Currency in USD Disclaimer
Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol ADTX
- Company Aditxt, Inc.
- Price $3.72
- Changes Percentage 758.45
- Change 3.29
- Day Low $0.41
- Day High $3.72
- Year High $14034.53
- Year Low $0.41
- Market Cap $80,139
- Price Avg 50 EMA (D) $6
- Price Avg 200 EMA (D) $508.51
- Exchange NASDAQ
- Volume 185,167
- Average Volume 282,219
- Open $0.42
- Previous Close $0.43
- EPS -6637.2
- PE 0.00
- Earnings Announcement 2026-03-09 04:00:00
- Shares Outstanding $21,515
Company brief: ADITXT, INC. (ADTX )
- Healthcare
- Biotechnology
- Mr. Amro A. Albanna
- https://www.aditxt.com
- US
- N/A
- 06-30-2020
- US0070256047
Aditxt, Inc., a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. It develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues. The company is also developing ADi products for organ transplantation, including skin grafting, autoimmune diseases, and allergies. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.
ADTX Corporation News
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
businesswire.com -- MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health innovations, announced today that it...